Baylor College of Medicine/Stanford University Clinical Genome Resource (CLINGEN)

Information

  • Research Project
  • 10270983
  • ApplicationId
    10270983
  • Core Project Number
    U24HG009649
  • Full Project Number
    2U24HG009649-05
  • Serial Number
    009649
  • FOA Number
    PAR-20-100
  • Sub Project Id
  • Project Start Date
    9/12/2017 - 7 years ago
  • Project End Date
    6/30/2026 - a year from now
  • Program Officer Name
    RAMOS, ERIN
  • Budget Start Date
    9/15/2021 - 3 years ago
  • Budget End Date
    6/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
  • Award Notice Date
    9/15/2021 - 3 years ago

Baylor College of Medicine/Stanford University Clinical Genome Resource (CLINGEN)

Project Summary/Abstract The Clinical Genome Resource (ClinGen) is an essential community resource developing clinically relevant genomic knowledge. Three research teams at Harvard/Geisinger, UNC/Kaiser and Baylor College of Medicine/Stanford have worked collaboratively since 2013 to create successful frameworks and software systems for sustained curation of the human genome. The landmark achievement in 2018 of FDA recognition as the first Public Human Genetic Variant Database significantly increased ClinGen's prominence as an innovative genome curation program. ClinGen's strategy has been highly successful: creating the training, framework and oversight for international expert panels (over 1400 members), while generating dynamic user- informed public tools including the ClinGen Curation Interfaces, Allele Registry and Linked Data Hub. This multi- institutional application from Baylor College of Medicine and Stanford University in response to PAR-20-100 Genomic Community Resources to support our ongoing development of the innovative advanced web technologies for software infrastructure that supports ClinGen?s gene, variant and actionability curation efforts. In this application we seek to operate at scale, generating procedures and informatics for high-throughput curation across ClinGen domains. We propose multiple improvements to scale our work through streamlined aggregation and linking of genomic and phenotypic data including sources from diverse populations (Aim 1) semi-automation for gene and variant curation (Aim 2) and actionability curation (Aim 3). We anticipate new facets of clinical genomics including standards for variant classification in hereditary and somatic cancer, forging novel curation approaches including curation of polygenic risk scores (PRS) and modeling curation of complex disorders in HLA-related rheumatologic and autoimmune diseases (Aim 4). We have developed innovative frameworks for appropriate use of ancestry and diversity in clinical genomics, while in parallel working to expand the diversity of the ClinGen workforce and users of ClinGen curated knowledge (Aim 5).

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    U24
  • Administering IC
    HG
  • Application Type
    2
  • Direct Cost Amount
    4316867
  • Indirect Cost Amount
    888409
  • Total Cost
    5205276
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    172
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NCI:500000\NHGRI:4705276\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZHG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BAYLOR COLLEGE OF MEDICINE
  • Organization Department
    PEDIATRICS
  • Organization DUNS
    051113330
  • Organization City
    HOUSTON
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    770303411
  • Organization District
    UNITED STATES